HERBIOTIC COMPLEX ORAL SOLUTION (Each 500ml contains Ephredrae herba 150mg/ Amygdalin 150g/ Calcium sulfate dihydrate 750g/ Glycyrrhizic acid 150g/ Sucrose 135g/ Benzoic acid 1.35g/ Ethylparaben 0.9g)

Indications

• Cancer treatment
• Pain relief in cancer patients
• Alternative therapy in malignancies

Dosage

Children: Refer to the BNF for Children for appropriate dosing information in the paediatric population.

Adults: Refer to the BNF for specific dosing recommendations, as doses may vary based on the formulation and clinical context.

Mechanism of action

Amygdalin is metabolized into its active components, including glucose, benzaldehyde, and hydrogen cyanide. The cyanide is thought to exert its effects by inhibiting cellular respiration, particularly in rapidly dividing cells, which has led to its investigation as an anticancer agent. However, the precise mechanism through which amygdalin may exert therapeutic effects remains unclear and is a subject of ongoing research.

Pharmacodynamics

The pharmacodynamics of amygdalin involve its conversion to active metabolites, notably cyanide, which can interfere with cellular metabolism and energy production. The toxicity of cyanide limits the therapeutic window of amygdalin, and its potential benefits in treating conditions like cancer must be weighed against the risk of cyanide poisoning. The overall clinical relevance of amygdalin remains uncertain due to insufficient evidence from rigorous clinical trials.

Pharmacokinetics

The pharmacokinetics of amygdalin are not well characterized, but it is known to be absorbed in the gastrointestinal tract. Following ingestion, it undergoes enzymatic hydrolysis, leading to the release of cyanide. The half-life of amygdalin and its metabolites is not well documented, and the potential accumulation of cyanide poses a significant risk, especially in cases of overdose or prolonged use.

Pregnancy

There is insufficient evidence regarding the safety of amygdalin during pregnancy. It is advised to avoid use unless prescribed by a healthcare professional.

Breast-feeding

Amygdalin is not recommended during breastfeeding due to potential risks. Consult a healthcare provider for guidance.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Topical treatment of fungal infections
• Preservative in food and pharmaceutical products
• Treatment of hyperammonemia (as part of a combination therapy)

Dosage

Children: Refer to specific product guidelines and clinical protocols for pediatric dosing information.

Adults: Refer to specific product guidelines and clinical protocols for dosing information.

Mechanism of action

Benzoic acid exerts its antimicrobial effects primarily by disrupting the integrity of microbial cell membranes, leading to cell lysis. It can also inhibit certain metabolic pathways in bacteria, such as the conversion of pyruvate to acetyl-CoA, thereby limiting energy production in these organisms.

Pharmacodynamics

Benzoic acid demonstrates a concentration-dependent antibacterial and antifungal activity. The efficacy of benzoic acid is influenced by the pH of the environment; it is more effective in acidic conditions. The compound acts on a broad spectrum of microorganisms, including some bacteria and fungi, making it a useful preservative and therapeutic agent.

Pharmacokinetics

Benzoic acid is absorbed through the gastrointestinal tract when ingested and can be metabolized in the liver. It is primarily excreted in the urine as hippuric acid after conjugation with glycine. The half-life of benzoic acid varies but is generally around 1 to 2 hours. Its distribution in the body is rapid, with a volume of distribution that suggests extensive tissue binding.

Adverse effects

• Allergic reactions
• Skin irritation
• Nausea
• Vomiting
• Headache

Precautions

• Use with caution in individuals with known hypersensitivity to benzoates
• Monitor for signs of hypersensitivity reactions

Pregnancy

The safety of benzoic acid during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Benzoic acid is excreted in breast milk. Caution is advised when administered to nursing mothers.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Formulations

• Topical creams
• Ointments
• Solutions

Indications

• Asthma
• Bronchospasm
• Nasal congestion
• Hypotension during anesthesia
• Obesity (as an appetite suppressant)

Dosage

Children: Refer to the BNF for Children for appropriate dosing.

Adults: Refer to the specific product guidelines or BNF for appropriate dosing.

Mechanism of action

Ephedra acts primarily as a sympathomimetic agent, stimulating the central nervous system and increasing the release of norepinephrine. This results in increased heart rate, bronchodilation, and reduced nasal congestion. It also has some direct effects on adrenergic receptors, particularly alpha and beta-adrenergic receptors.

Pharmacodynamics

The pharmacodynamics of ephedra involve stimulation of alpha- and beta-adrenergic receptors, which leads to vasoconstriction, increased heart rate, and bronchodilation. The release of norepinephrine enhances the body's metabolic rate and can lead to increased thermogenesis, making it potentially useful for weight loss and treating conditions like asthma.

Pharmacokinetics

Ephedra is absorbed rapidly from the gastrointestinal tract, with peak plasma concentrations occurring within 1 to 2 hours after administration. It is metabolized primarily in the liver and has a half-life of approximately 3 to 6 hours. The elimination of ephedra occurs mainly through the urine, with both unchanged drug and metabolites being excreted.

Contra-indications

• Severe hypertension
• Severe cardiovascular disease
• Hyperthyroidism
• Pheochromocytoma
• Glaucoma
• Pregnancy
• Breastfeeding

Adverse effects

• Nervousness
• Insomnia
• Dizziness
• Increased heart rate (tachycardia)
• Hypertension
• Nausea
• Vomiting
• Palpitations
• Headache
• Anxiety

Interactions

• Monoamine oxidase inhibitors (MAOIs)
• Sympathomimetics
• Caffeine
• Antihypertensive agents
• Beta-blockers

Precautions

• Use with caution in patients with cardiovascular disease
• Monitor blood pressure regularly
• Assess for potential for abuse or dependence
• Use cautiously in patients with a history of seizures

Pregnancy

Ephredrae is contraindicated during pregnancy due to potential risks to the fetus.

Breast-feeding

Ephredrae is not recommended during breastfeeding as it may affect milk production and the infant.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral tablets
• Liquid extracts
• Powdered forms

Indications

• Preservative in pharmaceutical formulations
• Preservative in cosmetic products
• Food preservative

Dosage

Children: Refer to specific product guidelines as dosing may vary based on formulation and intended use.

Adults: Refer to specific product guidelines as dosing may vary based on formulation and intended use.

Mechanism of action

Ethylparaben functions as a preservative by inhibiting the growth of various microorganisms. It acts primarily by disrupting the cell membrane integrity of bacteria and fungi, leading to cell lysis. The presence of ethylparaben alters the permeability of the microbial cell membrane, resulting in the leakage of essential cellular components, ultimately causing cell death.

Pharmacodynamics

Ethylparaben exhibits bactericidal and fungicidal activity, making it effective in controlling microbial growth in formulations. Its effectiveness is influenced by factors such as concentration, pH, and the presence of other components in the formulation. Ethylparaben is typically used in concentrations ranging from 0.1% to 0.8% in various products.

Pharmacokinetics

Ethylparaben is readily absorbed through the skin and mucous membranes. It undergoes hydrolysis to its active form, para-hydroxybenzoic acid, which then can be conjugated in the liver and excreted in the urine. The absorption and metabolism can vary based on the route of administration and the formulation in which it is used, but detailed pharmacokinetic data specific to ethylparaben is limited.

Pregnancy

Ethylparaben is generally considered safe for use during pregnancy, but it is advisable to consult a healthcare provider before use.

Breast-feeding

Ethylparaben is excreted in breast milk in small amounts. It is generally considered safe, but nursing mothers should consult a healthcare provider before use.

Storage

Store at room temperature, away from moisture and direct sunlight.

Formulations

• {'type': 'Topical', 'description': 'Ethylparaben is often used as a preservative in cosmetic and pharmaceutical formulations.'}
• {'type': 'Oral', 'description': 'Ethylparaben may also be found in some oral pharmaceutical products.'}

Indications

• Adrenal insufficiency
• Chronic inflammatory conditions
• Hepatitis
• Cirrhosis
• Adverse effects of corticosteroids

Dosage

Children: Refer to the BNF for Children for appropriate dosing based on age and weight.

Adults: Dosage varies based on the condition being treated. Refer to specific guidelines or the BNF for appropriate dosing.

Mechanism of action

Glycyrrhizic acid inhibits the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), which converts active cortisol to its inactive form cortisone. By inhibiting this enzyme, glycyrrhizic acid increases the levels of active cortisol, leading to enhanced glucocorticoid activity. It also exhibits anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines and modulating the immune response.

Pharmacodynamics

Glycyrrhizic acid demonstrates a range of pharmacodynamic effects, including anti-inflammatory, immunomodulatory, and antioxidant activities. It has been shown to reduce inflammation by inhibiting the nuclear factor kappa B (NF-κB) signaling pathway, leading to decreased expression of inflammatory mediators. Additionally, glycyrrhizic acid has potential benefits in liver protection and regulation of the hypothalamic-pituitary-adrenal (HPA) axis.

Pharmacokinetics

Following oral administration, glycyrrhizic acid is absorbed in the gastrointestinal tract and undergoes extensive metabolism, primarily in the liver. It has a bioavailability that can vary depending on dosage form and individual metabolism. Glycyrrhizic acid is known to have a long half-life, and its metabolites may have biological activity. Excretion occurs mainly through urine, with both unchanged glycyrrhizic acid and its metabolites being eliminated.

Contra-indications

• Hypersensitivity to glycyrrhizic acid or any component of the formulation
• Severe liver disease
• Hypertension
• Hypokalemia
• Corticosteroid therapy

Adverse effects

• Hypertension
• Hypokalemia
• Edema
• Headache
• Fatigue
• Muscle weakness
• Cardiac arrhythmias
• Gastrointestinal disturbances

Interactions

• Corticosteroids - may enhance the effects and side effects of corticosteroids
• Diuretics - may increase the risk of hypokalemia
• Digoxin - may enhance the effects of digoxin leading to toxicity
• Antihypertensives - may reduce the effectiveness of antihypertensive medications

Precautions

• Use with caution in patients with a history of hypertension
• Monitor blood pressure and potassium levels during prolonged use
• Consider potential interactions with other medications
• Use with caution in patients with a history of cardiac disease

Pregnancy

There is insufficient evidence on the safety of glycyrrhizic during pregnancy. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Caution is advised as glycyrrhizic may be excreted in breast milk. Consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral tablets
• Syrups
• Powders for reconstitution
• Topical preparations

Dosage

Children: Refer to specific pediatric herbal product guidelines, as dosage can vary based on the herb and intended use.

Adults: Refer to specific herbal product guidelines, as dosage can vary based on the herb and intended use.

Mechanism of action

The mechanism of action of herbal products is highly variable and depends on the specific herb being used. Generally, herbal compounds may exert their effects through multiple pathways, including modulation of immune response, antioxidant activity, anti-inflammatory effects, and interaction with various neurotransmitter systems. Some herbs may also influence metabolic pathways and exert effects on enzyme systems within the body.

Pharmacodynamics

Pharmacodynamics of herbal products varies based on the individual herb and its active constituents. Many herbs show a synergistic effect due to the presence of multiple compounds, which can enhance therapeutic outcomes and reduce side effects. Common pharmacodynamic effects include analgesic, anti-inflammatory, antimicrobial, and anxiolytic properties, among others. The efficacy and safety of herbal products often depend on factors such as dosage, preparation method, and individual patient response.

Pharmacokinetics

The pharmacokinetics of herbs can be complex due to the presence of multiple active compounds. Generally, herbal constituents are absorbed through the gastrointestinal tract, with bioavailability influenced by factors such as solubility, formulation, and the presence of other dietary components. Metabolism typically occurs in the liver via cytochrome P450 enzymes, with elimination primarily via renal pathways. However, specific pharmacokinetic parameters such as half-life, peak plasma concentration, and clearance rates can vary significantly among different herbs.

Pregnancy

The safety of herba during pregnancy has not been established. It is advisable to avoid use unless prescribed by a healthcare provider.

Breast-feeding

There is limited information regarding the safety of herba during breastfeeding. Caution is recommended.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Sweetening agent in food and beverages
• Ingredient in pharmaceutical formulations
• Source of quick energy

Dosage

Children: Refer to specific formulations and clinical guidelines for dosing, as sucrose does not have a standardized dosage. Typically used as needed for sweetening.

Adults: Refer to specific formulations and clinical guidelines for dosing, as sucrose does not have a standardized dosage. Typically used as needed for sweetening.

Mechanism of action

Sucrose is metabolized in the body to glucose and fructose, which are then used as energy sources. It does not have a specific pharmacological mechanism of action but contributes to energy metabolism via the glycolytic and citric acid pathways.

Pharmacodynamics

Upon ingestion, sucrose is hydrolyzed by the enzyme sucrase into its constituent monosaccharides, glucose and fructose. These monosaccharides are absorbed in the small intestine and enter the bloodstream, leading to a rise in blood glucose levels. This process provides a quick source of energy for cellular functions.

Pharmacokinetics

Sucrose is rapidly absorbed in the gastrointestinal tract after hydrolysis. Its absorption depends on the presence of sucrase in the intestine. Once in the bloodstream, glucose can be utilized by cells or stored as glycogen in the liver and muscles. The elimination half-life of sucrose itself is not well-defined as it is quickly broken down and utilized.

Pregnancy

Sucrose is generally regarded as safe during pregnancy when consumed in moderation as part of a balanced diet.

Breast-feeding

Sucrose is considered safe during breastfeeding when consumed in normal dietary amounts.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Oral solution
• Granules
• Tablets